Status:
RECRUITING
Power Prenatal Supplements for Sperm Quality
Lead Sponsor:
The Bird and Be Co Inc
Conditions:
Spermatogenesis and Semen Disorders
Infertility, Male
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
Male factor infertility is a leading cause of primary and secondary infertility. Poor sperm quality is defined as having an abnormal semen analysis \[WHO 2020 - https://www.who.int/publications/i/item...
Detailed Description
Male patients presenting to Conceive Health (https://conceivehealth.com/) or Reproductive Care Centre for infertility care will be potential candidates for this study. Male patients that have had a re...
Eligibility Criteria
Inclusion
- Male
- Age 18-45 years old
- Experiencing infertility
- A recent semen analysis confirming low count, motility or morphology (at least 1 of 3) - within last 3 months
- Low concentration: \< 15 Million / mL
- Low Motility: Progessive Motility \< 30%
- Morphology: Strict criteria: Normal forms \< 4% Reference: WHO 2020 6th edition: https://www.who.int/publications/i/item/9789240030787
Exclusion
- No diagnosed varicocele
- Younger than 18 years old
- Older than 45 years old
- Currently taking any form of antioxidant supplements(in last 3 months) besides a general multivitamin
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05410782
Start Date
November 1 2023
End Date
December 31 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Care Centre
Mississauga, Ontario, Canada, L5N 5S3